Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aldurazyme enzyme replacement therapy for MPS I
NL-OMON21663Active, not recruiting
- Sponsor
- Zorginstituut Nederland
- Start
- Jan 2004
- Modality
- Replacement Enzymes → Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Trial of laronidase, sponsored by Zorginstituut Nederland. Started Jan 2004; status: active, not recruiting.
02
Drugs
laronidase
Beyond the preview
Go deeper on NL-OMON21663.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON21663.